HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive process of nearly 300 applicants. It is the only ITP recipient focused on coronary artery disease (CAD), which affects 2.3 million people in the U.K., according to the British Heart Foundation.

Nemours Children’s Health System, a Florida-based health system with locations in six states, is now using in-house medical 3-D printing technology to create surgical models utilizing a U.S. Food and Drug Administration (FDA)-approved segmentation software. The software helps surgeons plan complex multidisciplinary cases in interventional radiology, cancer surgery and cardiac surgery. These models serve as a pre-planning blueprint and roadmap for Nemours surgeons and proceduralists, increasing confidence, reducing procedure times and minimizing unexpected findings while in the operating room.

Emerging medical device company Emboline Inc. announced it has completed a Series B funding round totaling over $10 million for its total embolic protection device for transcatheter aortic valve replacement (TAVR) procedures. The funding includes $3 million in new equity financing from multiple investors led by SV Tech Ventures and Shangbay Capital, and over $7 million in conversion of previously-issued convertible notes.